This webinar will provide an overview of the recently launched WHO Consolidated guidance on hepatitis B and C prevention, testing, treatment, service delivery and monitoring: an implementation handbook for a public health approach.
This guidance brings together more than a decade of WHO evidence-based recommendations into a single, practical reference for programme managers, policymakers, clinicians, donors, and partners. Released 10 years after WHO’s first global hepatitis strategy, it is designed to help countries move “from evidence-based recommendations to concrete action,” providing implementation pathways to expand equitable, person-centred hepatitis services at every level of the health system. It is presented in a modular, streamlined format covering prevention – including mother-to-child transmission and birth dose vaccination – testing, simplified treatment approaches, and data monitoring systems. By simplifying and consolidating WHO guidance, the handbook helps countries strengthen integrated hepatitis services and accelerate progress towards elimination by 2030.
Date and time
Thursday, 26 March 2026 | 12:30–14:00 CET
The webinar will be held in English.
Webinar objectives
- explain how the document helps turn policy into practical actions in different country contexts;
- share real-world country examples that show how hepatitis interventions can be scaled up; and
- discuss key barriers to implementation and possible practical solutions.
Key speakers
- Niklas Luhman, Medical Officer for Sexual Health, HIV and viral hepatitis; Île-de-France Regional Health Agency (ARS)
- Wendy Spearman, University of Cape Town, South Africa
- Su Wang, Cooperman Barnabas Medical Center, United States of America
- Dr Mohamed Hassany, Minister’s Assistant for Projects and Public Health Initiative, Executive director, The National Committee for Control of Viral Hepatitis NCCVH, Ministry of Health and Population, Cairo
- Dr Rabson Kachala, Deputy Director and Viral Hepatitis Program Led, Ministry of Health, Malawi
- Dr Tereza Kasaeva, Director, Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections, WHO
- Olufunmilayo Lesi, Viral Hepatitis Cross Cutting Lead, Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections, WHO
- Global partners from UNITAID, MPP (Medicines Patent Pool) and GAVI.
Moderator
Matteo Zignol, Unit Head, Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections, WHO